India has initiated a probe into the alleged dumping of Vitamin C, used by pharmaceutical firms for the production of medicines, from China following complaint by a domestic manufacturer.
Bajaj Healthcare Ltd has filed the application before the commerce ministry’s investigation arm DGTR, seeking initiation of the probe.
The company alleged that the domestic industry is impacted due to the dumping of Vitamin C from China PR and has requested for the imposition of anti-dumping duty on the imports, according to the notification of Directorate General of Trade Remedies (DGTR).
To read the full article, click here